Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9110927 | Cytokine | 2005 | 6 Pages |
Abstract
Data suggest that hydroxyurea up-regulates IL-13 secretion in anti-CD3-activated lymphocytes through gene activation but not by altered cell proliferation. Increased IL-13 secretion may contribute to unresponsiveness of certain SCD patients to hydroxyurea. The potential benefit of zileuton in the management of vasoocclusion is discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Solo Kuvibidila, B. Surendra Baliga, Renee Gardner, Lolie Yu, Raj Warrier, Maria Velez, David Ode, Johnson Haynes,